(Reuters) – Zynerba Pharmaceuticals Inc said on Thursday its cannabis -based gel succeeded in a mid-stage study of patients with Fragile X syndrome, … Read More
The post Zynerba’s cannabis -based gel succeeds in mid-stage study appeared first on Dagga Magazine.